Funding for this research was provided by:
NIH Office of the Director (UG1 OD024953, U24 OD024957, U24 OD024957, U24 OD024957, UG1 OD024953, UG1 OD024945, UG1 OD024952)
Received: 26 September 2022
Accepted: 5 October 2022
First Online: 28 October 2022
: This study is approved by the University of Arkansas for Medical Sciences Institutional Review Board. The potential participants will be provided with a written statement regarding the research (ICF + HIPAA) before the consent process. A waiver of consent documentation has been granted for adult participants (parents/caregivers). A full waiver of assent has been granted for children whose vaccine records are being reviews. Children will not have to sign an assent and/or verbally agree to be part of this study.
: Copies of the informed consent forms are available upon request.
: The authors declare that they have no competing interests.